Suzhou Fushilai Pharmaceutical Co., Ltd.

¥23.80As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301258Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (13.99%)
Div yield 0.92%
ROE (2.54%)
Biotechnology
Beta (5Y) 0.45
PE TTM —
TSR TTM (31.91%)
Mkt cap ¥2.108B
ROIC (5.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
10.84%
86.55%
Buy 11|0|1|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.35
0.35
0.39
0.41
16.26%
4.58%
13.05%
17.17%
Revenue¥M
269.3
270.1
273.5
288.7
7.19%
10.62%
7.48%
9.00%
Peers (US$316.1M)
Cap (US$)
PE
318.5M
72.74x
314.7M
—
301.1M
76.93x
Capital
TTM
5Y
10Y
Leveragex
1.092
0.052
0.047
EBIT/Intx
0.776
0.745
0.628
Own earn%
105.61
102.75
88.04
Sh yield%
7.77
35.34
36.97
Owners
Insiders/Inst%
13.33
76.52
Short interest%
1.49
SBC / revenue%
4.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
23–32
$1 testx
0.8
Incr. ROIC%
5